X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
2311 (164) 164
1506 (162) 162
rheumatology (150) 150
index medicus (115) 115
patients (80) 80
rheumatoid arthritis (77) 77
arthritis (75) 75
dk/atira/pure/subjectarea/asjc/2300/2311 (75) 75
waste management and disposal (75) 75
clinical and epidemiological research (63) 63
humans (60) 60
disease (57) 57
inflammation (52) 52
environmental sciences (49) 49
female (49) 49
studies (49) 49
male (48) 48
tumor necrosis factor-tnf (43) 43
adult (42) 42
environmental engineering (41) 41
dk/atira/pure/subjectarea/asjc/2300/2305 (40) 40
pollution (40) 40
clinical trials (39) 39
middle aged (39) 39
dk/atira/pure/subjectarea/asjc/2300/2310 (38) 38
analysis (35) 35
cytokines (35) 35
gene expression (35) 35
basic and translational research (32) 32
methotrexate (30) 30
autoimmune diseases (29) 29
treatment (29) 29
dmards (26) 26
lupus (26) 26
dk/atira/pure/subjectarea/asjc/2300/2304 (25) 25
environmental chemistry (25) 25
aged (24) 24
autoantibodies (24) 24
clinical medicine (24) 24
drug dosages (24) 24
health risk assessment (24) 24
systemic lupus erythematosus (24) 24
rheumatism (23) 23
safety (23) 23
severity of illness index (22) 22
immunoglobulins (21) 21
inflammatory diseases (21) 21
monoclonal antibodies (21) 21
pathogenesis (21) 21
rheumatic diseases (21) 21
tnf inhibitors (21) 21
double-blind (20) 20
engineering, environmental (20) 20
treatment outcome (20) 20
management (19) 19
proteins (19) 19
rheumatoid-arthritis (19) 19
anti-tnf (18) 18
lymphocytes (18) 18
therapy (18) 18
usage (18) 18
epidemiology (17) 17
flow cytometry (17) 17
genomes (17) 17
lymphocytes b (17) 17
population (17) 17
psoriasis (17) 17
spondyloarthritis (17) 17
double-blind method (16) 16
osteoarthritis (16) 16
care and treatment (15) 15
disease-activity (15) 15
tumors (15) 15
young adult (15) 15
biotechnology & applied microbiology (14) 14
dk/atira/pure/subjectarea/asjc/2100/2105 (14) 14
efficacy (14) 14
expression (14) 14
letter (14) 14
lymphocytes t (14) 14
pain (14) 14
phenotypes (14) 14
renewable energy, sustainability and the environment (14) 14
systematic review (14) 14
tumor necrosis factor (14) 14
classification (13) 13
leukocytes (13) 13
remission (13) 13
skin and connective tissue diseases (13) 13
adolescent (12) 12
antigens (12) 12
arthritis, rheumatoid - drug therapy (12) 12
chemokines (12) 12
disease activity (12) 12
dk/atira/pure/subjectarea/asjc/2300/2308 (12) 12
fibroblasts (12) 12
management, monitoring, policy and law (12) 12
nephritis (12) 12
questionnaires (12) 12
signal transduction (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue 6, pp. 890 - 897
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2018, Volume 77, Issue 9, pp. 1386 - 1387
Correspondence to Dr Mitsuhiro Akiyama, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi,... 
disease activity | cytokines | autoimmunity | chemokines | FIBROSIS | IGG4-RD | RHEUMATOLOGY | Chemokines, CC - blood | Immunoglobulin G4-Related Disease - diagnosis | Humans | Middle Aged | Adult | Female | Male | Biomarkers - blood | Case-Control Studies | Medicine | Disease | Cytokines | Internal medicine | Immunoglobulin G | Rheumatology | Fibroblasts | Biomarkers | Ligands | Chemokines | Pharmaceuticals | Letter | 2311 | 1506
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2018, Volume 77, Issue 1, pp. 30 - 39
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2019, Volume 78, Issue 11, pp. 1454 - 1462
BackgroundIn SELECT-COMPARE, a randomised double-blind study, upadacitinib 15 mg once daily was superior to placebo or adalimumab on background methotrexate... 
BLIND | PLACEBO | RHEUMATOLOGY | BARICITINIB | RECOMMENDATIONS | DISEASE | dmards (biologic) | methotrexate | Rheumatoid Arthritis | dmards (synthetic) | 1506 | 2311
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2019, Volume 78, Issue 8, pp. 1127 - 1134
ObjectivesThere is a need to identify effective treatments for rheumatic diseases, and while genetic studies have been successful it is unclear which genes... 
functional genomics | GWAS | rheumatic diseases | drug repositioning | SUSCEPTIBILITY LOCI | SECUKINUMAB | RHEUMATOLOGY | EFFICACY | PSORIATIC-ARTHRITIS | Drugs | Chromatin | Biological products | Disease | Genomics | Rheumatic diseases | Lymphocytes T | Genomes | Gene expression | Quality of life | Studies | Lymphocytes B | Rheumatoid arthritis | Genetics | Pharmaceutical industry | Miscellaneous | 2311 | 1506
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2019, Volume 78, Issue 3, pp. 372 - 379
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2019, Volume 78, Issue 5, pp. 672 - 675
ObjectivesNerve growth factor (NGF) has emerged as a key driver of pain in osteoarthritis (OA) and antibodies to NGF are potent analgesics in human disease.... 
chronic pain | vaccine | nerve growth factor | immunization | osteoarthritis | RHEUMATOLOGY | VACCINES | Immunization | Pain perception | Statistical analysis | Axonogenesis | Vaccination | Nerve growth factor | Arthritis | Vaccines | Virus-like particles | Analgesia | Analgesics | Immunotherapy | Surgery | Monoclonal antibodies | Pheochromocytoma cells | Osteoarthritis | Chronic illnesses | 2311 | 1506
Journal Article